Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA seq for PacR cells (Non-targeting vs siJunD)

ABSTRACT: This experiment investigates the effects of JunD depletion in Paclitaxel resistant L3.6pl pancreatic cancer cells

INSTRUMENT(S): NextSeq 2000

ORGANISM(S): Homo sapiens

SUBMITTER: Feda Hamdan

PROVIDER: E-MTAB-12705 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

4C-seq at iHUB regions in L3.6pl

Project description:Evaluation of interaction frequency in parental L3.6pl cells, paclitaxel-resistant cells and resistant cells treated with a CDK9 inhibitor

2023-04-21 | E-MTAB-11731 | biostudies-arrayexpress

ChIP seq for H4K5ac, JunD , and MED1 in Parental and Paclitaxel resistant L3.6pl cell line

Project description:Identification of occupancy for H4K5ac, MED1, and JunD in chemo resistance

2023-03-21 | E-MTAB-12707 | biostudies-arrayexpress

H3K4me3 HiChIP for Paclitaxel resistant L3.6pl pancreatic cancer cells (Non targeting vs siJunD)

Project description:Identification of JunD dependent interaction in paclitaxel resistance

2023-03-21 | E-MTAB-12708 | biostudies-arrayexpress

leChRO-seq in L3.6pl (Parental and Paclitaxel-resistant)

Project description:Evaluate the nascent RNA-seq production in L3.6pl

2023-03-24 | E-MTAB-11744 | biostudies-arrayexpress

H3K4me3 HiChIP for Paclitaxel resistant L3.6pl pancreatic cancer cells (Non targeting vs siJunD)

Project description:H3K4me3 HiChIP for Paclitaxel resistant L3.6pl pancreatic cancer cells (Non targeting vs siJunD)

| PRJEB60383 | ENA

ChIP seq for H4K5ac, JunD , and MED1 in Parental and Paclitaxel resistant L3.6pl cell line

Project description:ChIP seq for H4K5ac, JunD , and MED1 in Parental and Paclitaxel resistant L3.6pl cell line

| PRJEB60378 | ENA

RNA-seq of pancreatic cancer cells derived from a genetically engineered mouse model, which harbor the inducible KrasG12D allele

Project description:Pancreatic adenocarcinoma (PDAC) is a lethal disease and it is the most common type of pancreatic cancer. Majority of the pancreatic cancers harbor alterations in the Kras gene. Currently there are no approved drugs that target Kras directly and it's downstream effect on the epigenome remains unknown. In this study, we investigated the epigenetic landscape of pancreatic cancer cells which harbor the inducible KrasG12D allele. We performed RNA-seq, ChIP-seq against 6 different histone marks, ATAC-seq and RRBS to assess the changes in the epigenome after oncogenic KrasG12D induction.

2021-09-06 | E-MTAB-10896 | biostudies-arrayexpress

RNA-seq of human pancreatic cell lines, L3.6pl and BxPC-3, upon knockdown of p63 for 48 hours compared to siControl

Project description:Investigation of gene expression profile changes upon down regulation of p63 in L3.6pl and BxPC-3 cell lines which are representative of the squamous molecular subtype in pancreatic cancer

2018-12-18 | E-MTAB-7033 | biostudies-arrayexpress

Effect of ARID1A deficiency on transcriptome regulation during pancreatic cancer development and progression

Project description:In order to investigate the funcational and mechanistic role of ARID1A in regulating PDAC development and progression, we generated mRNA expression profiles from human pancreatic cancer cell line L3.6pl, which underwent ARID1A-depletion by CRISPR-Cas9 technology. The same-processed L3.6pl parental cell line was used as control.

2023-05-31 | GSE218822 | GEO

RRBS of pancreatic cancer cells derived from a genetically engineered mouse model, which harbor the inducible KrasG12D allele

2021-09-06 | E-MTAB-10900 | biostudies-arrayexpress